SILICON LABORATORIES INC. (SLAB)
SILICON LABORATORIES INC. (SLAB)
| Cash Flow | 2026-04-04 | 2026-01-03 | 2025-10-04 | 2025-07-05 |
|---|---|---|---|---|
| Net loss | -15,897 | -2,684 | -9,936 | -52,287 |
| Depreciation of property and equipment | 6,047 | 5,947 | 6,068 | 12,701 |
| Amortization of other intangible assets | 2,295 | 2,295 | 2,294 | 8,780 |
| Amortization of debt discount and debt issuance costs | NaN | 0 | NaN | NaN |
| Stock-based compensation expense | 21,055 | 20,679 | 20,040 | 39,605 |
| Equity-method loss | NaN | 0 | NaN | NaN |
| Deferred income taxes | 1,153 | -1,145 | 522 | 1,504 |
| Accounts receivable | 12,608 | -2,795 | 10,812 | 2,017 |
| Inventories | 7,616 | 13,324 | 1,315 | -24,631 |
| Prepaid expenses and other assets | -6,813 | 254 | -3,968 | -5,112 |
| Accounts payable | 3,387 | -4,808 | -1,671 | 12,812 |
| Other current liabilities and income taxes | -7,415 | 6,880 | 21,524 | 8,377 |
| Deferred revenue and returns liability | 4,463 | -3,088 | 4,591 | 783 |
| Other non-current liabilities | 3,257 | -4,943 | -951 | -6,965 |
| Net cash provided by operating activities | 4,934 | 8,350 | 34,322 | 53,036 |
| Purchases of marketable securities | 0 | 0 | 2,283 | 32,507 |
| Purchase of other investment | NaN | NaN | 4,000 | NaN |
| Sales of marketable securities | 0 | 61 | 346 | 14,986 |
| Proceeds from sale of equity investment | NaN | 0 | 0 | 0 |
| Maturities of marketable securities | 23,461 | 18,118 | 5,579 | 17,019 |
| Purchases of property and equipment | 9,837 | 9,980 | 6,393 | 13,549 |
| Purchases of other assets | NaN | 4,000 | NaN | NaN |
| Proceeds from capital-related government incentives | 1,265 | 578 | NaN | NaN |
| Net cash provided by (used in) investing activities | 14,889 | 8,777 | -6,751 | -14,051 |
| Proceeds from issuance of debt | NaN | 0 | NaN | NaN |
| Payments on debt | NaN | 0 | 0 | 0 |
| Proceeds from the issuance of common stock | NaN | 6,491 | 528 | 7,619 |
| Repurchases of common stock | NaN | 0 | NaN | NaN |
| Payment of taxes withheld for vested stock awards | 956 | 799 | 1,155 | 13,752 |
| Net cash used in financing activities | -956 | 5,692 | -627 | -6,133 |
| Increase in cash and cash equivalents | 18,867 | 22,819 | 26,944 | 32,852 |
| Cash and cash equivalents at beginning of period | 364,222 | 341,403 | 281,607 | NaN |
| Cash and cash equivalents at end of period | 383,089 | 364,222 | 341,403 | NaN |